MADISON, N.J., March 4, 2013 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that that it has been recognized in FORTUNE magazine's "World's Most Admired Companies" list as the No. 1 company in the Health Care industry category of "Pharmacy and Other Services."
"We are proud that Quest Diagnostics has rejoined FORTUNE's World's Most Admired Companies as the leader in our category," said Steve Rusckowski, President and CEO. "This accomplishment reflects the passion of our employees, who every day empower better health with diagnostic insights for people throughout the communities we serve."
FORTUNE's list of Most Admired Companies is based on surveys of thousands of executives, directors and securities analysts based on nine criteria: innovation, people management, use of corporate assets, quality of management; social responsibility; financial soundness, long-term investment, quality of products and services, and global competitiveness.
The ranking for Quest Diagnostics may be found online at http://money.cnn.com/magazines/fortune/most-admired/2013/snapshots/10577.html
About Quest Diagnostics
Quest Diagnostics is the world's leading provider of diagnostic information services that patients and doctors need to make better healthcare decisions. The company offers the broadest access to diagnostic information services through its network of laboratories and patient service centers, and provides interpretive consultation through its extensive medical and scientific staff. Quest Diagnostics is a pioneer in developing innovative diagnostic tests and advanced healthcare information technology solutions that help improve patient care. Additional company information is available at QuestDiagnostics.com. Follow us at Facebook.com/QuestDiagnostics and Twitter.com/QuestDX.
Quest, Quest Diagnostics, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks are the property of their respective owners.
Quest Diagnostics Contacts: Dan Haemmerle (Investors): 973-520-2900 Wendy Bost (Media): 973-520-2800
SOURCE Quest Diagnostics